Paroxysmal nocturnal haemoglobinuria.

Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria. J Exp Med (1985) 3.33

Paroxysmal nocturnal haemoglobinuria with renal, infective and immunological abnormalities. Postgrad Med J (1981) 0.75

Paroxysmal nocturnal hemoglobinuria. Proc R Soc Med (1976) 0.75

Paroxysmal nocturnal haemoglobinuria-like defect in red cells in chronic lymphatic leukaemia. Br Med J (1976) 0.75

Cardiac surgery report cards: comprehensive review and statistical critique. Ann Thorac Surg (2001) 4.26

Neutrophils in development of multiple organ failure in sepsis. Lancet (2006) 3.64

Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med (1995) 3.60

Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood (2001) 2.99

Lassa fever in the United States. Investigation of a case and new guidelines for management. N Engl J Med (1990) 2.57

The use of SI units in reporting results obtained in hospital laboratories. J Clin Pathol (1974) 2.55

The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. N Engl J Med (1997) 2.41

Acute abdomen during adjuvant chemotherapy: superior mesenteric artery thrombosis associated with CMF chemotherapy. Clin Oncol (R Coll Radiol) (2001) 2.01

A stable standard suspension for red-cell counts. Lab Pract (1966) 1.96

A simple and reliable method for estimating haemoglobin. Bull World Health Organ (1995) 1.94

The effects of different levels of dietary restriction on aging and survival in the Sprague-Dawley rat: implications for chronic studies. Aging (Milano) (2001) 1.93

Quality control in haematology: report of interlaboratory trials in Britain. Br Med J (1969) 1.80

Demand or ideation? Evidence from the Iranian marital fertility decline. Demography (1995) 1.80

The use of 51Cr-labelled heat-damaged red cells to study splenic function. I. Evaluation of method. Br J Haematol (1966) 1.73

Progress in laboratory control of oral anticoagulants. Lancet (1982) 1.72

Interpretation of measured red cell mass and plasma volume in adults: Expert Panel on Radionuclides of the International Council for Standardization in Haematology. Br J Haematol (1995) 1.70

Monitoring the acute phase response. BMJ (1988) 1.69

P nucleotides in V(D)J recombination: a fine-structure analysis. Mol Cell Biol (1993) 1.64

ICSH review of the measurement of the erythocyte sedimentation rate. Int J Lab Hematol (2011) 1.60

Attitudes toward genetic research review: results from a survey of human genetics researchers. Public Health Genomics (2011) 1.58

ESR or CRP? A comparison of their clinical utility. Hematology (2007) 1.58

Hereditary erythroblastic multinuclearity associated with a positive acidified-serum test: a type of congenital dyserythropoietic anaemia. Br J Haematol (1969) 1.58

Nitric oxide and the control of firefly flashing. Science (2001) 1.56

The haematological complications of polycythaemia vera and treatment with radioactive phosphorus. Br J Radiol (1966) 1.54

'Non-tropical idiopathic splenomegaly' ('primary hypersplenism'): a review of ten cases and their relationship to malignant lymphomas. Br J Haematol (1969) 1.53

Field evaluation of a novel haemoglobin measuring device designed for use in a rural setting. S Afr Med J (1997) 1.53

High frequency of anti-endomysial reactivity in candidates to heart transplant. Dig Liver Dis (2002) 1.49

Red cell alloantibodies in thalassemia major. Results of an Italian cooperative study. Transfusion (1985) 1.46

Status of present and candidate international reference preparations (IRP) of thromboplastin for the prothrombin time. A report of the Subcommittee for Control of Anticoagulation. Thromb Haemost (1993) 1.45

Functional characterization of B lymphocytes generated in vitro from embryonic stem cells. Proc Natl Acad Sci U S A (1999) 1.45

Outcomes of a program to evaluate mother and baby 6 months after umbilical cord blood donation. Transfusion (2001) 1.44

Hairpin coding end opening is mediated by RAG1 and RAG2 proteins. Mol Cell (1998) 1.44

Stenting for in-stent restenosis: A long-term clinical follow-up. Catheter Cardiovasc Interv (1999) 1.43

Recommendations for reference method for haemoglobinometry in human blood (ICSH standard 1995) and specifications for international haemiglobinocyanide standard (4th edition). J Clin Pathol (1996) 1.43

Allogeneic bone marrow transplantation for primary myelofibrosis. Br J Haematol (1989) 1.43

Frequency, risk factors, and outcome for bacteremia after percutaneous transluminal coronary angioplasty. Am J Cardiol (1997) 1.40

The aplastic anaemia--paroxysmal nocturnal haemoglobinuria syndrome. Br J Haematol (1967) 1.40

Placental blood collection: effects on newborns. Blood (1995) 1.39

Universal leucocyte-depletion of blood components: cell concentrates and plasma. Vox Sang (2001) 1.39

The 'cherry buffy-coat syndrome', a cause of decreased platelet yield in platelet concentrates obtained from buffy-coats. Vox Sang (2001) 1.38

Evaluation of the haemoglobin colour scale. Bull World Health Organ (2002) 1.38

Electron-microscope studies of the red cell in paroxysmal nocturnal haemoglobinuria. Br J Haematol (1965) 1.36

Developmental trajectories of disruptive behavior problems in preschool children of adolescent mothers. Child Dev (1999) 1.28

Splenic atrophy in adult coeliac disease: is it reversible? Gut (1981) 1.28

A familial dysfunction of the eight component of complement (C8). Clin Immunol Immunopathol (1980) 1.26

Hempas: congenital dyserythropoietic anaemia (type II). Q J Med (1973) 1.23

A rapid thin-layer chromatographic system for Romanowsky blood stains. Stain Technol (1974) 1.23

Clinical and ultrastructural aspects of congenital dyserythropoietic anaemia type I. Br J Haematol (1972) 1.22

Paroxysmal nocturnal haemoglobinuria: clinical manifestations, haematology, and nature of the disease. Ser Haematol (1972) 1.20

RNA-binding protein HuR mediates cytoprotection through stimulation of XIAP translation. Oncogene (2010) 1.17

Dyserythropoiesis and dyserythropoietic anemias. Prog Hematol (1973) 1.16

Cardiac haemolytic anaemia. Semin Hematol (1969) 1.15

Reliability and clinical impact of the normalization of the prothrombin times in oral anticoagulant control. Thromb Haemost (1985) 1.15

Automated differential leucocyte counting: the present state of the art. Br J Haematol (1977) 1.14

Antibodies to hepatitis C virus in Italian blood donors. Lancet (1989) 1.14

Dysplastic anaemias. Nouv Rev Fr Hematol (1973) 1.13

Increased distribution and expression of CD64 on blood polymorphonuclear cells from patients with the systemic inflammatory response syndrome (SIRS). Clin Exp Immunol (2001) 1.12

Erythroid hypoplasia in myelofibrosis: a feature associated with blastic transformation. Br J Haematol (1977) 1.11

Post-traumatic stress disorder: a right temporal lobe syndrome? J Neural Eng (2010) 1.11

Role of the reticuloendothelial system in the anaemia of rheumatoid arthritis. A study using the 59Fe-labelled dextran model. Ann Rheum Dis (1974) 1.11

Problems in the introduction of SI units,. J Clin Pathol (1975) 1.10

A report on the interlaboratory quantitation of haemoglobin A2 and haemoglobin F. J Clin Pathol (1973) 1.08

The effect of stimulus-response compatibility on cortical motor activation. Neuroimage (2001) 1.07

Radionuclide distribution following injection of 111Indium-labelled platelets. Br J Haematol (1980) 1.07

Clinical use of WHO haemoglobin colour scale: validation and critique. J Clin Pathol (2000) 1.07

The synchronous neural interactions test as a functional neuromarker for post-traumatic stress disorder (PTSD): a robust classification method based on the bootstrap. J Neural Eng (2010) 1.07

Two types of dysfunctional eighth component of complement (C8) molecules in C8 deficiency in man. Reconstitution of normal C8 from the mixture of two abnormal C8 molecules. J Clin Invest (1983) 1.06

Influence of different hepatitis C virus genotypes on the course of asymptomatic hepatitis C virus infection. Gastroenterology (1996) 1.06

IRES in distress: translational regulation of the inhibitor of apoptosis proteins XIAP and HIAP2 during cell stress. Cell Death Differ (2005) 1.05

Studies of splenic function in the myeloproliferative disorders and generalized malignant lymphomas. Br J Haematol (1971) 1.05

Quality assessment of transfusion practice in elective surgery. Transfusion (1988) 1.05

Point-of-care method for total white cell count: an evaluation of the HemoCue WBC device. Int J Lab Hematol (2008) 1.05

Immune lysis of AET-treated normal red cells (PNH-like cells). Nature (1967) 1.04

Risk of Kaposi's sarcoma-associated herpes virus transmission from donor allografts among Italian posttransplant Kaposi's sarcoma patients. Blood (1997) 1.04

Measurement of splenic red cell volume and visualization of the spleen with 99mTc. J Nucl Med (1973) 1.03

The incidence and risk factors of community-acquired hepatitis C in a cohort of Italian blood donors. Hepatology (1997) 1.03

Microbiology and ration digestibility in the hindgut of the ovine. Appl Environ Microbiol (1985) 1.03

Primary health screening by haemoglobinometry in a tropical community. Bull World Health Organ (1989) 1.02

Continuous distributions of specific ventilation recovered from inert gas washout. J Appl Physiol Respir Environ Exerc Physiol (1978) 1.02

Cell volume studies in B-cell leukaemia. Br J Haematol (1980) 1.02

A rapid and simple method for reversing the inhibitory effect of heparin on PCR for HLA class II typing. PCR Methods Appl (1993) 1.02

Dyserythropoiesis and dyserythropoietic anaemia. Br J Haematol (1972) 1.01

Umbilical cord blood banking: evaluation of the collection procedure and of CFU-GM content. J Hematother (1993) 1.00

Automated platelet counting--a re-evaluation of the sedimentation method. Clin Lab Haematol (1981) 1.00

Kaposi's sarcoma-associated herpesvirus infection and multiple myeloma. Science (1997) 0.99

Acute myocardial infarction in diabetes mellitus and significance of congestive heart failure as a prognostic factor. Am J Cardiol (1988) 0.99

Determinants of reproductive success across sequential episodes of sexual selection in a firefly. Proc Biol Sci (2012) 0.99

Elution correction in 51Cr red cell survival studies. Br J Haematol (1974) 0.98

Urgent coronary bypass surgery for failed percutaneous coronary intervention in the stent era: Is backup still necessary? Am Heart J (2001) 0.98

Measurement of splenic red-blood-cell mass with radioactive carbon monoxide. Lancet (1968) 0.98

Platelet counting-development of a reference method and a reference preparation. Clin Lab Haematol (1979) 0.98

A procedure for assaying commercial samples of eosin. Stain Technol (1975) 0.97

Effects of pulsed electromagnetic fields on Steinberg ratings of femoral head osteonecrosis. Clin Orthop Relat Res (1989) 0.96

Surface structure of normal and leukaemic lymphocytes. I. Effect of mitogens. Clin Exp Immunol (1972) 0.96

hnRNP A1 regulates UV-induced NF-kappaB signalling through destabilization of cIAP1 mRNA. Cell Death Differ (2008) 0.96

Quality assurance of clinical transfusion practice by implementation of the privilege of blood prescription and computerized prospective audit of blood requests. Transfus Med (1996) 0.96

True associations between resting fMRI time series based on innovations. J Neural Eng (2011) 0.96

Elution of 111Indium from reticuloendothelial cells. J Clin Pathol (1982) 0.95

Synovial iron deposition in rheumatoid arthritis. Arthritis Rheum (1973) 0.95

Transitional myeloproliferative disorder. Br J Haematol (1979) 0.95